MedPath

Pharmaceutical Companies

BioLine Rx logo

BioLine Rx

๐Ÿ‡ฎ๐Ÿ‡ฑIsrael
Ownership
Public
Established
2003-01-01
Employees
79
Market Cap
$59.2M
Website
http://www.biolinerx.com
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell...
Intensity Therapeutics logo

Intensity Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
-
Employees
17
Market Cap
$59.2M
Website
http://www.intensitytherapeutics.com
Intensity Therapeutics, Inc. operates as biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer...
Gritstone Bio logo

Gritstone Bio

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2015-01-01
Employees
231
Market Cap
$57.5M
Website
http://www.gritstonebio.com
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham...

Cytosorbents

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
186
Market Cap
$56.6M
Website
-
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was...

MURAL ONCOLOGY, INC.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$56M
Website
-
SCYNEXIS, Inc. logo

SCYNEXIS, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
1999-01-01
Employees
51
Market Cap
$56M
Website
http://www.scynexis.com

HOOKIPA Pharma

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
179
Market Cap
$55.9M
Website
-
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its...

Aerovate

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
51
Market Cap
$54.2M
Website
-
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary...
Aileron Therapeutics logo

Aileron Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2005-01-01
Employees
15
Market Cap
$52.4M
Website
http://www.aileronrx.com
Reneo Pharmaceuticals logo

Reneo Pharmaceuticals

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2014-01-01
Employees
8
Market Cap
$52.1M
Website
http://www.reneopharma.com
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to...
ยฉ Copyright 2025. All Rights Reserved by MedPath